CUDC-907
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CUDC-907, covering 2018-12-21 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma [Phase 1]